A. Serrano

Methylenetetrahydrofolate reductase polymorphism (677 C>T) predicts long time to progression in metastatic colon cancer treated with 5-fluorouracil and folinic acid.

M. Santibáñez, L. Herrera, G. Calderillo, 2010, Archives of medical research.

Acute pancreatitis secondary to ifosfamide.

J. Varon, G. Sternbach, R. Gerson, 1997, The Journal of emergency medicine.

F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.

A. Dueñas-González, D. Pérez-Montiel, L. Cetina, 2011, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

A phase II study of gemcitabine plus cisplatin in previously untreated advanced ovarian cancer.

G. Calderillo, J. G. De la Garza, A. Serrano, 2006, Anticancer research.

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

C. Pérez-Plasencia, A. Dueñas-González, E. Pérez-Cárdenas, 2007, BMC Cancer.

Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients.

A. Dueñas-González, T. Wegman, L. Cetina, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

F 18-FDG-PET / CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma

A. Dueñas-González, L. Cetina, A. Serrano, 2013 .

[Recurrence and survival rates among early breast cancer cases with triple negative immunophenotype].

R. Gerson, A. Serrano, A. Villalobos, 2008, Gaceta Médica de México.